Watson Labs Teva Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?
WATSON LABS TEVA has fifty approved drugs.
There are two tentative approvals on WATSON LABS TEVA drugs.
Drugs and US Patents for Watson Labs Teva
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Teva | LEVOTHYROXINE SODIUM | levothyroxine sodium | TABLET;ORAL | 207588-011 | May 10, 2022 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs Teva | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203959-004 | Apr 18, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Watson Labs Teva | SIMVASTATIN | simvastatin | TABLET;ORAL | 076685-002 | Dec 20, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for WATSON LABS TEVA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Here is a list of applicants with similar names.